The molecular genetics of hypertrophic cardiomyopathy

Current Opinion in Cardiology

Volumn 12, Issue 3, 1997, Pages 295-302

  Malik, M Shahzad A ^a   Watkins, Hugh ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACTILE PROTEIN; MYOSIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; POLYPEPTIDE;

GENE LOCUS; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 0030992683     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199705000-00011     Document Type: Review

References (39)

1. Geisterfer-Lowrance A, Kass S, Tanigwa G, Vosberg H, McKenna W, Seidman C, Seidman J: A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy-chain gene missense mutation. Cell 1990, 62:999-1006.
2. Thierfelder L, Watkins H, MacRae C, Lamas R, Vosberg H, McKenna W, Seidman C, Seidman J: Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 1994, 77:701-712.
3. Watkins H, Conner D, Thierfelder L, Jarcho J, MacRae C, McKenna W, Maron B, Seidman J, Seidman C: Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet 1995, 11:434-437. Two unrelated families were found to show linkage to the CMH4 locus. A splice donor mutation in the MyBP-C gene was identified in one family, and a duplication mutation was identified in the other. Both mutations were thought to be likely to interfere with myosin heavy-chain binding.
4. Bonne G, Carrier L, Bercovici J, Cruaud C, Richard P, Hainque B, Gautel M, Labeit S, James M, Beckmann J, et al.: Cardiac myosin binding-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet 1995, 11:438-440. The authors report a mutation in the MyBP-C gene in two related French families previously linked to the CMH4 locus. They propose that the mutation most likely results in a truncated protein product or a null allele.
5. Poetter K, Jiang H, Hassanzadeh S, Master S, Chang A, Dalakas M, Rayment I, Sellers J, Fananapazir L, Epstein N: Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet 1996, 13:63-69. Missense mutations in the ELC and RLC of myosin are described and are found to be associated with a rare HCM phenotype. In vitro studies of myosin with these mutations are reported. The mutations are suggested to impair the stretch activation response of cardiac papillary muscle.
6. MacRae C, Ghaisas N, Kass S, Donnelly S, Basson C, Watkins H, Ryuichiro A, Thierfelder L, McGarry K, Rowland E, et al.: Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest 1995, 96:1216-1220. First paper to report the locus that is mutated to cause FHC or Wolff-Parkinson-White syndrome.
7. Santorelli F, Mak S-C, Vasquez-Acevedo M, Gonzalez-Astiazaran A, Ridaura-Sanz C, Gonzalez-Halphen D, DiMauro S: A novel mitochondrial DNA point mutation associated with mitochondrial encephalocardiomyopathy. Biochem Biophys Res Commun 1995, 216:835-840.
8. Leu gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. J Med Genet 1995, 32:654-656.
9. Casali C, Santorelli F, D'Amati G, Bernucci P, DeBiase L, DiMauro S: A novel mtDNA mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun 1995, 213:588-593. First report of a mitochondrial mutation producing typical hypertrophic cardiomyopathy without other phenotypic features of mitochondrial disease.
10. Jamieson C, van-der-Burgt I, Brady A, van-Reen M, Elsawi M, Hol F, Jeffery S, Patton M, Mariman E: Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet 1994, 8:357-360.
11. Campuzano V, Montermini L, Molto M, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, et al.: Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 1996, 271:1423-1427.
12. Maron B, Bonow R, Cannon R, Leon M, Epstein S: Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987, 316:780-789.
13. McKenna W: Hypertrophic cardiomyopathy. In Diseases of the Heart. Edited by Julian D, Camm A, Fox K, Hall R, Poole-Wilson P. London: Bailliere Tindall; 1989:933-950.
14. Watkins H, Rosenzweig A, Hwang D-S, Levi T, McKenna W, Seidman C. Seidman J: Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992, 326:1108-1114.
15. Anan R, Greve G, Thierfelder L, Watkins H, McKenna W, Solomon S, Vecchio C, Shono H, Nakao S, Tanaka H, et al.: Prognostic implications of novel β cardiac myosin heavy-chain gene mutations that cause familial hypertrophic cardiomyopathy. J Clin Invest 1994, 93:280-285.
16. Seidman C, Seidman J: Gene mutations that cause familial hypertrophic cardiomyopathy. In Molecular Cardiovascular Medicine. Edited by Haber E. New York: Scientific American; 1995:193-210.
17. Watkins H, McKenna W, Thierfelder L, Suk H, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec C, Seidman J, Seidman C: Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995, 332:1058-1064.
18. Lechin M, Quinones M, Omran A, Hill R, Yu Q-T, Rakowski H, Wigle D, Liew C, Sole M, Roberts R, Marian A: Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995, 92:1808-1812.
19. Gautel M, Zuffardi O, Freiburg, A, Labeit S: Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: a modu-lator of cardiac contraction? EMBO J 1995, 14:1952-1960.
20. Okagaki T, Weber F, Fischman D, Vaughan K, Mikawa T, Reinach F: The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif. J Cell Biol 1993, 123:619-626.
21. Warrick H, Spudich J: Myosin structure and function in cell motility. Annu Rev Cell Biol 1987, 3:379-421.
22. Chothia C, Lesk A: The relation between the divergence of sequence and structure in proteins. FMBO J 1986, 5:823-826.
23. Rayment I, Holden H, Whittaker M, Yohn C, Lorenz M, Holmes K, Milligan R: Structure of the actin-myosin complex and its implications for muscle contraction. Science 1993, 261:58-65.
24. Rayment I, Rypniewski WR, Schmidt-Base K, Smith R, Tomchick D, Benning M, Winkelmann D, Wesenberg G, Holden H: Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 1993, 261:50-58.
25. Rayment I, Holden H, Sellers J, Fananapazir L, Epstein N: Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Nail Acad Sci U S A 1995, 92:3864-3868.
26. Tohtong R, Yamashita H, Graham M, Haeberle J, Simcox A, Maughan D: Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory light chain. Nature 1995, 374:650-653.
27. Steiger G: Stretch activation and myogenic oscillation of isolated contractile structures of heart muscle. Pflugers Arch 1971, 330:347-361.
28. Herskowitz I: Functional inactivation of genes by dominant negative mutations. Nature 1987, 329:219-222.
29. Tanigawa G, Jarcho J, Kass S, Solomon S, Vosberg H, Seidman J, Seidman C: A molecular basis for familial hypertrophic cardiomyopathy: an alpha/beta cardiac myosin heavy-chain hybrid gene. Cell 1990, 62:991-998.
30. Bejsovec A, Anderson P: Functions of the myosin ATP and actin binding sites are required for C. elegans thick filament assembly. Cell 1990, 60:133-140.
31. Straceski J, Geisterfer-Lowrance A, Seidman C, Seidman J, Leinwand L: Functional analysis of myosin missense mutations in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A 1994, 91:589-593.
32. Nishi H, Kimura A, Harada H, Koga Y, Adachi K, Matsuyama K, Koyanagi T, Yasunaga S, Imaizumi T, Toshima H, Sasazuki T: A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. Circulation 1995, 91:2911-2915.
33. Geisterfer-Lowrance A, Christe M, Conner D, Ingwall J, Schoen F, Seidman C, Seidman J: A mouse model of familial hypertrophic cardiomyopathy. Science 1996, 272:731-734. Reports the generation of an HCM mouse model by the introduction of the Arg403Gln mutation into the α cardiac myosin heavy-chain gene. Resultant cardiac histologic and physiologic changes and the effects of exercise are described.
34. Leinwand L, Fournier R, Nadal-Ginard B, Shows T: Multigene family for sarcomeric myosin heavy chain in mouse and human DNA: localization on a single chromosome. Science 1983, 221:766-769.
35. Jaenicke T, Diederich K, Haas W, Schleich J, Lichter P, Pfordt M, Bach A, Vosberg H: The complete sequence of the human beta-myosin heavy-chain gene and a comparative analysis of its product. Genomics 1990, 8:194-206.
36. Maron B, Roberts W, Epstein S: Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. Circulation 1982, 65:1388-1394.
37. Sweeney H, Straceski A, Leinwand L, Tikunov B, Faust L: Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 1994, 269:1603-1605.
38. Lankford EB, Epstein ND, Fananapazir L, Sweeney HL: Abnormal contractile properties of muscle fibers expressing beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy. J Clin Invest 1995, 95:1409-1414.
39. Lin D, Bobkova A, Homsher E, Tobachman L: Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy. J Clin Invest 1996, 97:2842-2848. Rat cardiac troponin T containing the He79Asn mutation was found to have 50% faster thin filament movement than normal. The relationship between this and altered cardiac contraction in patients with HCM is discussed.